| Dr Robert Noyes Lowe, MD | |
|
2501 Marshall Ave, Suite A, Newport News, VA 23607-4636 | |
| (757) 247-3910 | |
| (757) 245-0203 |
| Full Name | Dr Robert Noyes Lowe |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2501 Marshall Ave, Newport News, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134158470 | NPI | - | NPPES |
| 6707441 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101047865 (Virginia) | Primary |
| 208000000X | Pediatrics | 0101047865 (Virginia) | Primary |
| Entity Name | Pediatrics & Internal Medicine Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427178193 PECOS PAC ID: 5092875419 Enrollment ID: O20081114000630 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).
Natural killer, or NK cells, are part of our innate immune system. A healthy body produces them to respond early during infection. They are activated and they kill cells infected with a given virus.
Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.
A study by York University researchers has found that infants between one and three months old develop more rapidly when adults refrain from imitating their noises and facial expressions, and socialize with them instead.
› Verified 7 days ago
| Entity Name | Starting Point Of Virginia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760949127 PECOS PAC ID: 9931535820 Enrollment ID: O20200213000787 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).
Natural killer, or NK cells, are part of our innate immune system. A healthy body produces them to respond early during infection. They are activated and they kill cells infected with a given virus.
Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.
A study by York University researchers has found that infants between one and three months old develop more rapidly when adults refrain from imitating their noises and facial expressions, and socialize with them instead.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Noyes Lowe, MD 2501 Marshall Ave, Suite A, Newport News, VA 23607-4636 Ph: (757) 247-3910 | Dr Robert Noyes Lowe, MD 2501 Marshall Ave, Suite A, Newport News, VA 23607-4636 Ph: (757) 247-3910 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).
Natural killer, or NK cells, are part of our innate immune system. A healthy body produces them to respond early during infection. They are activated and they kill cells infected with a given virus.
Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.
A study by York University researchers has found that infants between one and three months old develop more rapidly when adults refrain from imitating their noises and facial expressions, and socialize with them instead.
› Verified 7 days ago
Brian K Butcher, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11835 Fishing Point Dr, Ste 207, Newport News, VA 23606 Phone: 757-873-3334 Fax: 757-873-1128 | |
Connie Swartz Ketten, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 680 Oyster Point Rd, Newport News, VA 23606 Phone: 757-668-4851 | |
Raymond Amaker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 500 J Clyde Morris Blvd, Hampton Roads Neonatology, Newport News, VA 23601 Phone: 757-594-2000 | |
Dr. Amber A Mccusker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 321 Main St Ste 1, Newport News, VA 23601 Phone: 757-595-0358 Fax: 757-595-6745 | |
Richard Raymond Brzeski, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Newport News, VA 23601 Phone: 757-595-0358 Fax: 757-595-6745 | |
Sherin Amiri, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11760 Rock Landing Dr, Newport News, VA 23606 Phone: 757-539-0251 Fax: 757-539-8008 | |
Amanda M Hedges, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 2 Bernardine Dr, Newport News, VA 23602 Phone: 757-886-6000 |